Clinical Trials Directory

Trials / Terminated

TerminatedNCT03506659

Electrochemical Skin Conductance in Evaluation of Chronic Neuropathy électrochimique cutanée

Electrochemical Skin Conductance in Evaluation of Chronic Neuropathy

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
4,000 (actual)
Sponsor
Erasme University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Use of cutaneous electrochemical conductance for preclinical screening of small-caliber nerve fibers

Detailed description

Objective: Use of cutaneous electrochemical conductance for preclinical screening of small-caliber nerve fibers Background: Sudoscan is a tool developed to evaluate and screen peripheral neuropathies in diabetes. His indication has been extended to other neuropathies such as post-chemotherapy, Fabry's disease, Parkinson's disease, familial amyloid polyneuropathy. Main objective: Evaluation of the relevance of cutaneous electrochemical conductance in chronic peripheral neuropathies. Methodology : Recruitment of 2 groups of 2000 patients Group 1: Patients with chronic neuropathy, during clinic bread consultation Group 2: Patients to benefit from scheduled surgery seen during anesthesia consultation For both groups filling the central awareness inventory questionnaire Analysis of the results after the recruitment has been completed.

Conditions

Interventions

TypeNameDescription
DEVICESUDO-SCAN DeviceSudo-scan is a machine with 2 palets for hands and 2 palets for foots. The patient has to put his 2 hands and 2 foots on the machine. The machine do the measures during 2 minutes.

Timeline

Start date
2018-03-01
Primary completion
2020-01-30
Completion
2020-01-30
First posted
2018-04-24
Last updated
2020-02-28

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03506659. Inclusion in this directory is not an endorsement.